2024/08/31
é¶çšéºäŒåçµæãçã¯ã¯ãã³ã®ç¬¬äžçš®äœ¿çšçã«é¢ãã審æ»çµæã«ã€ããŠã®æèŠã»æ
å ±ã®åéã«ã€ããŠhttps://public-comment.e-gov.go.jp/pcm/detail?CLASSNAME=PCMMSTDETAIL&id=550003977&Mode=0ã解説
é¶çšãšã¯ãããéºäŒåçµæãã¯ã¯ãã³ã䜿ãã°ã鿥çã«ããã«ãæªåœ±é¿ããããã§ãæ°æã¡ãããããŸããã
ãšã¯ãã£ãŠãããã§ã«äººã«å¯ŸããŠïœRNAã¯ã¯ãã³ãšããã³ãã³äœ¿ã£ãŠããã§ãæé
ããšãã説ããããŸãããå°ãã§ããªã¹ã¯ã®ãããã®ã¯é£ãæ¢ããªããã°ã§ãã
ãæŠèŠ
èŸ²ææ°Žç£çã¯ãé¶çšéºäŒåçµæãçã¯ã¯ãã³ã®æ¿èªç³è«ïŒä»¶ãåãã審æ»ãè¡ããŸããããã®éãåŠèçµéšè
ããã¯ãçç©å€æ§æ§ã«åœ±é¿ãçãããããã¯ãªããšã®æèŠãåŸãŸããããã®æèŠãèžãŸããç³è«æžé¡ã«èšèŒãããŠããå
容ã®åŠ¥åœæ§ã確èªããã®ã§å¯©æ»å ±åæžããŸãšããŸããããããã®å¯©æ»å ±åæžã«ã€ããŠãåºãåœæ°ã®çæ§ããæèŠã»æ
å ±ãåéããããŸãã
èŸ²ææ°Žç£çåã³ç°å¢çã§ã¯ãæåºããã ããæèŠã»æ
å ±ãèæ
®ããäžã§ãæ¬ä»¶ã®æ¿èªã倿ããããšãšããŠãããŸãããªããæåºããã ããæèŠã«å¯ŸããŠãåå¥ã®åçã¯èŽããããŸãã®ã§ããããããåŸ¡äºæ¿é¡ããŸãã
èš
ïŒ æèŠå
¬åã®èæ¯ã»è¶£æšã»ç®ç
ïŒïŒïŒéºäŒåçµæãçã¯ã¯ãã³ã®çç©å€æ§æ§ã«å¯Ÿãã圱é¿è©äŸ¡
éºäŒåçµæãçã¯ã¯ãã³ã®äœ¿çšçã«åœãã£ãŠã¯ãæãåœã®éç忀ç©ã«åœ±é¿ãäžããªããããéºäŒåçµæãçç©çã®äœ¿çšçã®èŠå¶ã«ããçç©ã®å€æ§æ§ã®ç¢ºä¿ã«é¢ããæ³åŸïŒå¹³æ 15 幎æ³åŸç¬¬ 97 å·ã以äžãã«ã«ã¿ããæ³ããšãããïŒã«åºã¥ãããã®äœ¿çšçã«é¢ããèŠçšïŒç¬¬äžçš®äœ¿çšèŠçšïŒãå®ãããããèŸ²ææ°Žç£çåã³ç°å¢çã«ç³è«ããæ¿èªãåããå¿
èŠããããŸãã
ïŒïŒïŒå¯©æ»åã³å¯©æ»å ±åæž
èŸ²ææ°Žç£çã¯ãéºäŒåçµæã蟲äœç©ã®å¯©æ»ã»ç®¡çã®èœåãéææ§åã³ç§åŠçäžè²«æ§ãåäžãããããã審æ»ã»ç®¡çã®æšæºçãªæé ããŸãšãããéºäŒåçµæã蟲äœç©ã®ã«ã«ã¿ããæ³ã«åºã¥ã審æ»ã»ç®¡çã«ä¿ãæšæºæé æžãïŒå¹³æ 22 å¹ŽïŒæ 31æ¥å
¬è¡šã以äžãæšæºæé æžããšãããïŒãå®ããŠããŸãã
ïŒæšæºæé æžïŒ
https://www.maff.go.jp/j/syouan/nouan/carta/about/index.html#2éºäŒåçµæã蟲äœç©ã®ç¬¬äžçš®äœ¿çšèŠçšã®æ¿èªç³è«ã®å¯©æ»ã«ã€ããŠãæšæºæé æžã«åºã¥ãã審æ»ã®çµè«ã審æ»ã®æŠèŠçããæãå ±åæžãšããŠãŸãšããããšãšãªã£ãŠããŸãã
ïŒïŒïŒä»åã®ç³è«ã»å¯©æ»
ä»åãã«ã«ã¿ããæ³ã«åºã¥ã第äžçš®äœ¿çšèŠçšã®æ¿èªãåããããã«ç³è«ã®ãã£ã奿·»ã®é¶çšéºäŒåçµæãçã¯ã¯ãã³ã«ã€ããŠãã«ã«ã¿ããæ³ãšæšæºæé æžãšã䜵ããŠã審æ»ãè¡ããŸããããã®éãåŠèçµéšè
ããã¯ãæ¿èªç³è«ã®ãã£ã第äžçš®äœ¿çšèŠçšã«åŸã£ãŠäœ¿çšããå Žåã«ãçç©å€æ§æ§ãžã®åœ±é¿ãçãããããã¯ãªããšã®æèŠãåŸãŸããããããèžãŸããé¶çšéºäŒåçµæãçã¯ã¯ãã³ã®ç¬¬äžçš®äœ¿çšèŠçšã®æ¿èªç³è«ã®å¯©æ»ã«ã€ããŠãæšæºæé æžã«æºããŠã審æ»å ±åæžããŸãšããŸããã
â審æ»å ±åæžïŒ97ããŒãžïŒ
https://public-comment.e-gov.go.jp/pcm/download?seqNo=0000277570ïŒïŒç¬¬äžçš®äœ¿çšèŠçšã®æ¿èªç³è«ã«ä¿ã審æ»ã®çµè«
ãŸãšãã£ã¹ã»ãžã£ãã³æ ªåŒäŒç€Ÿããã什åïŒå¹ŽïŒæïŒæ¥ä»ãã§æ¿èªç³è«ã®ãã£ããäŒææ§ãã¡ããªããŠã¹å¢ç
ç±æ¥ VP2 èçœè³ªçºçŸéºäŒåå°å
¥äžé¢é³¥ãã«ãã¹ãŠã€ã«ã¹ HVT-IBD #9 æ ªïŒIBDV VP2, Meleagrid herpesvirus 1)ïŒä»¥äžãæ¬éºäŒåçµæããŠã€ã«ã¹ããšãããïŒãã«ã€ããŠãçç©å€æ§æ§åœ±é¿è©äŸ¡ãè¡ã£ãã
æ¬éºäŒåçµæããŠã€ã«ã¹ã®å®¿äž»ã¯ã1969 幎ã«å¥åº·ãªäžé¢é³¥ããåé¢ãããéç
åæ§ã®äžé¢é³¥ãã«ãã¹ãŠã€ã«ã¹(以äžãHVTããšããã)ã§ããããã¬ãã¯ç
ãŠã€ã«ã¹ïŒä»¥äžãMDVããšãããïŒãšã®è¡æž
åŠç亀差æ§ã瀺ããMDVè¡æž
å3ãšåé¡ãããŠãããç
åæ§MDVã¯ãMDVè¡æž
å1ã§ãããé¶ã®ç¥çµçŸæ£ãæªæ§ãªã³ãè
«ã䞻城ãšãããã¬ãã¯ç
ãåŒãèµ·ããããããã«å¯ŸããHVTã¯éç
åæ§ã§ãããMDVè¡æž
å1ã®é²åŸ¡æäœãèªå°ããåããæã¡ããã¬ãã¯ç
ã«å¯Ÿããçã¯ã¯ãã³æ ªãšããŠäœ¿çšãããŠããã
æ¬éºäŒåçµæããŠã€ã«ã¹ã¯å®¿äž»ãšåæ§ã®ç¹æ§ãæã¡ãé¶ã«ææããŠãç
埵ã瀺ãããé¶ããé¶ãžã®äŒéæ§ã¯èªããããªãã
ãŸããæ¬éºäŒåçµæããŠã€ã«ã¹ã«ã¯ãäŒææ§ãã¡ããªããŠã¹å¢ç
ãŠã€ã«ã¹ïŒä»¥äžãIBDVããšãããïŒã®é²åŸ¡æåãçºçŸããIBDVVP2 éºäŒåãæ¿å
¥ãããŠãããããè¥éœ¢é¶ã«äŒææ§ã®é«ãçŸç
ã§é«çãªèŽæ»ãå
ç«æå¶ãèµ·ããIBDVãé²åŸ¡ããäžåæäœãèªå°ãããIBDVã®ææã黿¢ããããšãã§ããã
審æ»ã®æŠèŠã¯ãæ¬å ±åæžã®ïŒã®ãšããã§ãããåŠèçµéšè
ããã¯ãæ¬éºäŒåçµæããŠã€ã«ã¹ã®æ¿èªç³è«ã®ãã£ã第äžçš®äœ¿çšèŠçšã«åŸã£ãŠäœ¿çšããå Žåã«ãçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããšããçç©å€æ§æ§åœ±é¿è©äŸ¡ã®çµè«ã¯åŠ¥åœã§ãããšã®æèŠãåŸãŠãããããããèžãŸããæ¬ç³è«ã«åºã¥ã䜿çšã«ã€ããŠãçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããšå€æããã
ïŒïŒå¯©æ»ã®æŠèŠ
æ¬éºäŒåçµæããŠã€ã«ã¹ã®å®¿äž»ã¯ãHVT FC126 æ ªã§ããããã¬ãã¯ç
ã¯ã¯ãã³è£œé çšæ ªãšããŠç±³åœèŸ²åçïŒã«æ¿èªãããŠããããã¹ã¿ãŒã·ãŒããŠã€ã«ã¹ããé¶èç·ç¶èœçްèïŒCEFïŒçްèã§ïŒä»£ç¶ä»£ããããã®ã§ããããã¬ãã¯ç
ã¯ãè
«çåæ§ãæãã MDV è¡æž
å 1 ã«å±ããåŒ·æ¯æ ªã®ææã«èµ·å ããŠãããé¶ã®ç¿Œéº»çºãè麻çºãæé ãšãã£ãç¥çµçŸæ£ãæªæ§ãªã³ãè
«ã䞻城ãšããäŒææ§ã®é«ãçŸç
ã§ãããHVT ãã¯ã¯ãã³ãšããŠé¶ã«æ¥çš®ãããšãäœå
ã§è¡æ¶²äžã«å
¥ãçœè¡çã«ããå
šèº«ã«ç§»åãããã¬ãã¯ç
ææã«å¯Ÿããæµææ§ãä»äžãããããªããHVT ã¯ãéç
åæ§ã§æ¬æ¥ã®ä¿æåç©ã§ããäžé¢é³¥ã«ææããŠãç
埵ãåããªãç¹æ§ãããããŸããæææ§ãæã€çްèéé¢åãŠã€ã«ã¹ç²åãææé³¥é¡ã®çŸœå
äžç®çްèã§ã®ã¿ç£çããããã®åŸãèœå±ïŒãã±ïŒãšããŠç°å¢äžã«ææ³ãããããé¶éã®æ°Žå¹³äŒéã¯éå®çã§ããããšãææè©Šéšã§ç¢ºèªãããŠãããããã«ãHVT ã¯é¶ã®çŸœå
äžç®çްè以å€ã®å
šãŠã®çµç¹ã§ã¯çްèé䌎æ§ã瀺ãã现èå€ã«æŸåºããããšæææ§ã倱ããæ°Žå¹³äŒéãéå®çã§ããããšããç°å¢äžã§ã®æææ¡å€§ã®å¯èœæ§ã¯èãé£ãã
ãŸããæ¬éºäŒåçµæããŠã€ã«ã¹ã«ã¯ IBDVVP2 éºäŒåãæ¿å
¥ãããŠããã
IBDV ã¯çŽ 6.1 kb ã® äºæ¬é RNA ãŠã€ã«ã¹ã§ãããè¥éœ¢é¶ã«äŒææ§ãé«ããé¶ã®ãªã³ãçã®ååã«é¢äžããåšå®ã§ãããã¡ããªããŠã¹å¢å
ã§å¢æ®ããå
ç«æå¶ãèµ·ããããã®çµæãé¶ã«çŸœæ¯éç«ãŠãäžç¢ãæ²é¬±ãšãã£ãçç¶ãã¿ãããèŽæ»ç㯠50%以äžã§ããããšãç¥ãããŠãããIBDVVP2 éºäŒåãçºçŸãã VP2 èçœè³ªã¯ãŠã€ã«ã¹ç²åã®è¡šé¢ã«é²åºããŠäžåæäœ 1ãèªå°ããèçœè³ªèªäœã«ã¯æ¯æ§ãç
åæ§ã¯ãªãã
IBDV VP2 éºäŒåçºçŸã«ã»ããã¯ã宿䞻 HVT FC126 æ ªã²ãã ã®éºäŒåéã®é翻蚳é åã«å®¿äž»æ žé
žã®æ¬ æãªãã« 1 ã³ããŒæ¿å
¥ãããŠãããHVT ã²ãã ã®äžã§ç¹ã«ä¿åæ§ã®é«ãé åã«äœçœ®ããŠããã飿¥é åã«ã¯èª¿ç¯å åã®ååšã¯ç¥ãããŠããªãã
æ¬éºäŒåçµæããŠã€ã«ã¹ã®å®¿äž»åã³çšããããéºäŒåçµæãæè¡ãèæ
®ããæ¬éºäŒåçµæããŠã€ã«ã¹ã®çç©å€æ§æ§åœ±é¿ãçããããå¯èœæ§ã«ã€ããŠãïŒïŒïŒä»ã®åŸ®çç©ãæžå°ãããæ§è³ªãïŒïŒïŒç
åæ§ãïŒïŒïŒæå®³ç©è³ªã®ç£çæ§åã³ïŒïŒïŒæ žé
žãæ°Žå¹³äŒéããæ§è³ªã®ïŒã€ã®é
ç®ããè©äŸ¡ãè¡ã£ãã
1 ç
åäœãæææ§ç²åã 现è ã«å¯ŸããŠåãŒãçç©åŠçãªåœ±é¿ãäžåããŠã现èãé²åŸ¡ããæäœã§ããã
(1) ä»ã®åŸ®çç©ãæžå°ãããæ§è³ªïŒç«¶åãæå®³ç©è³ªã®ç£çã«ããä»ã®åŸ®çç©ãæžå°ãããæ§è³ªïŒ
宿䞻ã®å±ããåé¡åŠäžã®çš®ã§ãã HVT ã¯ãäžé¢é³¥ãèªç¶å®¿äž»ãšããéç
åæ§2ãŠã€ã«ã¹ã§ãäžé¢é³¥éã§æ°Žå¹³äŒéããããé¶ã«å¯ŸããŠãæææ§ããããèªç¶ç°å¢ã«éåšãããHVT ã¯ãMDV ãšã®è¡æž
åŠç亀差æ§ãæã€ããšããã1970 幎代ã®åé ãããã¬ãã¯ç
ãäºé²ããã¯ã¯ãã³ãšããŠåžè²©ããã宿䞻ã§ãã HVT FC126 æ ªã¯ããã¬ãã¯ç
ã® HVT çã¯ã¯ãã³ãšããŠæãäžè¬çãªæ ªã§ããã
æ¿å
¥ãããŠãã IBDVVP2 éºäŒåã¯ããŠã€ã«ã¹ç²åã®è¡šé¢ã«é²åºãäžåæäœãèªå°ãããŠã€ã«ã¹èçœè³ªãçºçŸããããèçœè³ªèªäœã«ã¯æ¯æ§ãç
åæ§ããªããIBDV VP2 éºäŒåã¯ã宿䞻 HVT FC126 æ ªã²ãã ã®é翻蚳é åã«å®¿äž»æ žé
žã®æ¬ æãªãã«æ¿å
¥ãããŠãããæ¿å
¥ãµã€ãã¯ãHVT ã²ãã ã®äžã§ç¹ã«ä¿åæ§ã®é«ãé åã«äœçœ®ãã飿¥é åã«ã¯èª¿ç¯å åã®ååšã¯ç¥ãããŠããªãã
ãããã®ããšãããæ¬éºäŒåçµæããŠã€ã«ã¹ã§ã¯ã宿䞻ãŠã€ã«ã¹ HVT FC126 æ ªã®ORF2ã«æ¹å€ã¯ãªããéºäŒåã®çºçŸçã調ç¯ããæ©èœãæããå¯èœæ§äžŠã³ã«ä»ã®åŸ®çç©ã«å¯Ÿããç
åæ§åã³æå®³ç©è³ªãç£çããå¯èœæ§ã¯æ¥µããŠäœãã
ãŸããæ¬éºäŒåçµæããŠã€ã«ã¹ãå¹é€çްèã§ 8 代ç¶ä»£å¹é€ããŠåŸããŠã€ã«ã¹ãšç¶ä»£åã®ãŠã€ã«ã¹ãšã®æ§ç¶ã«å·®éã¯èªãããããæ¬éºäŒåçµæããŠã€ã«ã¹ã®äŸäžæ žé
žã®å®å®æ§ã確èªãããŠããã
ãŸããæ¬éºäŒåçµæããŠã€ã«ã¹ã 18 æ¥éœ¢ SPF çºè²é¶åµã«åµå
æ¥çš®ããåµååŸ 7 å㯠8 æ¥ç®ã«èŸèåã³è¡æ¶²äžã®çœè¡çããã®ãŠã€ã«ã¹ã®ååã 5 代ç¶ä»£ãããšãããåœè©²é¶ã®èšåºçç¶åã³åæ€ã«ããã¬ãã¯ç
åã¯äŒææ§ãã¡ããªããŠã¹å¢ç
ã«èµ·å ãããšèããããç
å€ã¯èªãããããç
åæ§ã埩垰ããªãã£ãããšã瀺ãããã
ããã«ãåç¶ä»£ã®ååãããŠã€ã«ã¹ã CEF3 现èã§å¹é€ããDNA æœåºã㊠PCR4ã«ãã確èªãããšãããéºäŒåæ¬ æã®ãã³ãã¯èªãããããIBDV VP2 éºäŒåã®å®å®æ§ã確èªãããååãããŠã€ã«ã¹ã®ãŠã€ã«ã¹éæž¬å®æã«å®æœããäºéå
ç«æè²ã«ãããå
šãŠã®ãã©ãŒã¯ã« VP2 èçœè³ªãçºçŸããŠããããšã確èªãããããšãããåœè©²é¶ã®ç¶ä»£ã«ãããŠãç§»å
¥ãããæ žé
žã®è€è£œç©ã®çºçŸãå®å®ããŠããããšã瀺ãããã
æ¬éºäŒåçµæããŠã€ã«ã¹ãçºè²é¶åµã«æ¥çš®ãã詊éšã§ã¯ãåµåããé¶ããéå®çãªãŠã€ã«ã¹ã®ææ³ããã³åå±
ããé¶ãžã®æ°Žå¹³äŒéãèªãããããããã®çšåºŠã¯ HVTã§ã®æ¢ç¥ã®çšåºŠãšåçã§ããããšã確èªãããã
æ¬éºäŒåçµæããŠã€ã«ã¹ãšå®¿äž»ãŠã€ã«ã¹ã®å¹é€çްèã«ããã墿®èœã«ã€ããŠæ¯èŒãããããå¹é€çްèã®ãŠã€ã«ã¹éãçµæçã«æž¬å®ãããšããã宿䞻ãŠã€ã«ã¹ãžã®IBDV VP2 éºäŒåã®æ¿å
¥ã«ãã£ãŠãŠã€ã«ã¹ã®å¢æ®èœãé«ãŸã£ãŠããªãããšã確èªãããã
ãããã®ããšãããæ¬éºäŒåçµæããŠã€ã«ã¹ã®äŸäžæ žé
žã®å®å®æ§ã確èªããã宿䞻 HVT FC126 æ ªãšæ¯èŒããŠæ¬éºäŒåçµæããŠã€ã«ã¹ã®å¢æ®èœã®äžæã¯ã¿ãããªãã£ãããŠã€ã«ã¹ã®ææ³åã³åå±
ããé¶ãžã®æ°Žå¹³äŒéã®çšåºŠã¯ HVT ãšåçã§ããããšã瀺ãããå
åšæ§ãŠã€ã«ã¹ã®æŽ»æ§ååã³ç
åæ§ä»äžã®å¯èœæ§ã¯èããããªãããšãããç«¶åã«ããä»ã®åŸ®çç©ãæžå°ãããæ§è³ªã«ã€ããŠã¯ãHVT ãšåæ§ã«äœããšèããããã
2 ãªãŒãã³ãªãŒãã£ã³ã°ãã¬ãŒã ïŒè±: open reading frameãORFïŒïŒç¿»èš³ãããèœåãæã€ãªãŒãã£ã³ã°ãã¬ãŒã ã®éšåã®ããšã§ããããããã翻蚳ããèçœè³ªãäœãããã
3 çºè²é¶åµ,ãã¯ããªèå
ç·ç¶èœçްè(è±: chicken embryonic fibroblasts ãCEF)
4 ããªã¡ã©ãŒãŒé£éåå¿ïŒè±: polymerase chain reactionãPCRïŒïŒDNA ãµã³ãã«ã®ç¹å®é åãå¢å¹
ãããåå¿ãå°éã® DNA ãµã³ãã«ãããã®è©³çްãè§£æããã«ååãªéã«ãŸã§å¢å¹
ããããšãç®çã§ããã
以äžã«ãããä»ã®åŸ®çç©ãæžå°ãããæ§è³ªã«èµ·å ããŠåœ±é¿ãåããå¯èœæ§ã®ããéç忀ç©çã¯ç¹å®ãããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããä»ã®åŸ®çç©ãæžå°ãããæ§è³ªã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
(2) ç
åæ§ïŒéçåç©ã«ææãããããã®éçåç©ã®çæ¯ã«æ¯éãåãŒãæ§è³ªïŒHVT FC126 æ ªã¯é¶ãäžé¢é³¥åã³ãŠãºã©ã«ææããããšã確èªãããŠããã
æ¬éºäŒåçµæããŠã€ã«ã¹ã¯ IBDV VP2 èçœè³ªãçºçŸããããšä»¥å€ã¯ã宿䞻 HVT FC126 æ ªã®ç¹æ§ãåãç¶ãã§ãããæ¬éºäŒåçµæããŠã€ã«ã¹ããé¶ãäžé¢é³¥ããŠãºã©åã³ããŠã¹ã«æ¥çš®ãã詊éšã§ã¯ããããã®äŸè©Šåç©ãšãèšåºçã«å¥åº·ã§ãããç°åžžã¯èªããããªãã£ãã
äžæ¹ãMDV ã¯ãŠãºã©ãäžé¢é³¥ãããžãæ°çš®ã®ã«ã¢ãã¬ã³çã®éçåç©ã«ãææããããã¹ãºã¡ãã€ããŠãºã©ããããã¯ãžã£ã¯çå€ãã®ä»ã®é³¥é¡åã³åºä¹³é¡ã«ã¯ææããªããšãããŠãããHVT 㯠MDV ãšã®è¡æž
åŠç亀差æ§ãæã€ããšããMDV ãææããåç©ã«ã¯ HVT ãææããå¯èœæ§ã¯åŠå®ã§ããªããã宿䞻 HVT FC126 æ ªã®æææ§ã確èªãããŠããªãåç©çš®ã«ææããæåæ§ã®é«ãé¶ãšåç以äžã«æ¬éºäŒåçµæããŠã€ã«ã¹ãææ³ããããšã¯èãããããæææºã«ãªããšã¯èãé£ãããŸããéçåç©ãžã®æææ§ã«é¢ããŠã¯ãäžé¢é³¥ãšç³»çµ±çã«é ãéçé³¥é¡ãžã®èªç¶æææ§ã¯äœããšèããããã
æ¬éºäŒåçµæããŠã€ã«ã¹ã¯ HVT ãšåæ§ã«ã矜å
äžç®çްè以å€ã¯çްèé䌎æ§ã§ã现èå€ã«æŸåºããããšæææ§ã倱ããæ¬éºäŒåçµæããŠã€ã«ã¹ãçºè²é¶åµã«æ¥çš®ãã詊éšã§ã¯ãåµåããé¶ããã¯éå®çãªãŠã€ã«ã¹ã®ææ³åã³åå±
ããé¶ãžã®æ°Žå¹³äŒéãèªãããããããã®çšåºŠã¯ãHVT ãšåçã§ããããšã瀺ãããã
ãŸããIBDV VP2 èçœè³ªã¯ IBDV ã®äž»èŠãªãŠã€ã«ã¹æ§é èçœè³ªã§ãäžåæäœå¿çèªå°ãæ
ããIBDV VP2 èçœè³ªèªäœã«ã¯æ¯æ§ãç
åæ§ããªãã
æ¬éºäŒåçµæããŠã€ã«ã¹ãåœè©²é¶ããååããååãããŠã€ã«ã¹ãé¶ã§ 5 代ç¶ä»£ããããèšåºçç¶åã³åæ€ã«ãããŠããã¬ãã¯ç
åã¯äŒææ§ãã¡ããªããŠã¹å¢ç
ã«é¢é£ããæèŠã瀺ãé¶ã¯èªãããããç
åæ§ã埩垰ããªãã£ãããšã瀺ãããããã®ããšãããæ¬éºäŒåçµæããŠã€ã«ã¹ãéçåç©ã®çæ¯ã«æ¯éãåãŒãæ§è³ªã«é¢ããŠã¯ãHVT ãšåæ§ã«éåžžã«äœããšèããããã
以äžã«ãããç
åæ§ã«èµ·å ããŠåœ±é¿ããããå¯èœæ§ã®ããéç忀ç©çã¯ç¹å®ãããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéãç
åæ§ã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
(3) æå®³ç©è³ªã®ç£çæ§ïŒéçåç©ã®çæ¯åã¯çè²ã«æ¯éãåãŒãç©è³ªãç£çããæ§è³ªïŒ
宿䞻ã®å±ããåé¡åŠäžã®çš®ã§ãã HVT ã«ã€ããŠã¯ãæå®³ç©è³ªã®ç£çæ§ã¯ç¥ãããŠããªããæ¬éºäŒåçµæããŠã€ã«ã¹ã®å®¿äž»ãŠã€ã«ã¹ã§ãã HVT FC126 æ ªãæå®³ç©è³ªã®ç£çæ§ã¯èªããããŠãããã䜿çšå®çžŸã«ãããŠã¢ã¬ã«ã²ã³ã«é¢ããåé¡ã¯å ±åãããŠããªãããšããæå®³ç©è³ªãç£çããå¯èœæ§ã¯ãªããšèããããã
æ¬éºäŒåçµæããŠã€ã«ã¹ã¯ãIBDV VP2 èçœè³ªãçºçŸãã以å€ãåºæ¬çãªçç©åŠçæ§ç¶ã¯å®¿äž»ãŠã€ã«ã¹ãšåäžã§ãããIBDV VP2 èçœè³ªã¯IBDVã®äž»èŠãªãŠã€ã«ã¹æ§é èçœè³ªã§ãVP2ã¯é²åºéšã«èŠªæ°Žæ§ã®å¯å€é åãæã€ãVP2ã®é²åºéšã¯ã¢ããé
ž206-350ã®éã®èçœè³ªã«èªããããææããåç©ã®äžåæäœå¿çèªå°ãæ
ãã
IBDV VP2 èçœè³ªèªäœã«æ¯æ§ãç
åæ§ããªãããšãã¢ã¬ã«ã²ã³ããŒã¿ããŒã¹ïŒåœç«å»è¬åé£åè¡çç ç©¶æïŒã«ãããŠIBDV VP2ã®ã¢ããé
žé
åãšææãªçžåæ§ã瀺ãé
åã¯èªããããªãã£ãããšãããæ¬éºäŒåçµæããŠã€ã«ã¹ã«æå®³ç©è³ªã®ç£çæ§ã¯ãªããšèããããã
ãŸããæ¬éºäŒåçµæããŠã€ã«ã¹ããé¶ãäžé¢é³¥ããŠãºã©åã³ããŠã¹ã«æ¥çš®ãã詊éšã§ã¯ããããã®äŸè©Šåç©ãšãèšåºçã«å¥åº·ã§ãããç°åžžã¯èªããããªãã£ããé¶ã«æ¥çš®ãã詊éšã§ã¯ããŠã€ã«ã¹ã®ææ³åã³åå±
æææ§ã¯å®¿äž»ã§ããHVT FC126æ ªãšåçšåºŠã§ãã£ãã
IBDVVP2 éºäŒåçºçŸã«ã»ããã¯ã宿䞻 HVT FC126 æ ªã²ãã ã®éºäŒåéã®é翻蚳é åã«å®¿äž»æ žé
žã®æ¬ æãªãã«æ¿å
¥ãããHVTã²ãã ã®äžã§ç¹ã«ä¿åæ§ã®é«ãé åã«äœçœ®ãã飿¥é åã«ã¯èª¿ç¯å åã®ååšã¯ç¥ãããŠããªããããéºäŒåã®çºçŸçã調ç¯ããæ©èœãæããå¯èœæ§åã³æå®³ç©è³ªãç£çããå¯èœæ§ã¯æ¥µããŠäœãã
以äžã«ãããIBDV ã®ç
åæ§ã«ä¿ãæå®³ç©è³ªãã¢ã¬ã«ã®ãŒæ§ç©è³ªçæå³ããªãæ°ããªç©è³ªã®ç£çã¯ãªããæå®³ç©è³ªã®ç£çæ§ã«èµ·å ããŠåœ±é¿ãåããå¯èœæ§ã®ããéç忀ç©çã¯ç¹å®ãããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããæå®³ç©è³ªã®ç£çæ§ã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
(4) æ žé
žãæ°Žå¹³äŒéããæ§è³ªïŒéºäŒåçµæãçç©çã®äœ¿çšçã®èŠå¶ã«ããçç©ã®å€æ§æ§ã®ç¢ºä¿ã«é¢ããæ³åŸïŒå¹³æ 15 幎æ³åŸç¬¬ 97 å·ïŒã察象ãšããæè¡ã«ããç§»å
¥ãããæ žé
žãéç忀ç©åã¯ä»ã®åŸ®çç©ã«äŒéããæ§è³ªïŒ
HVTïŒMDV è¡æž
å 3ïŒãšä»ã®è¡æž
åïŒMDV è¡æž
å 1 å㯠MDV è¡æž
å 2ïŒã®ãŠã€ã«ã¹éã®çµæãã®å¯èœæ§ãèããããããå®éã«ã¯å®éšå®€å
ã«ãã㊠MDV è¡æž
å 1 ãš MDV è¡æž
å 2 ã®çµæãã 1 ä»¶å ±åãããŠããã®ã¿ã§ããã以å€ã¯ãé·å¹Žã«ãããåçš®è¡æž
åãã¬ãã¯ç
ã¯ã¯ãã³ã®éå€äœ¿çšå®çžŸã«ãããŠãã®ãããªäºè±¡ã¯å ±åãããŠããªããHVT ãš MDV éã®çµæãã®å¯èœæ§ãäœãèŠå ãšããŠã¯ããã¯ã¬
ãªããã¬ãã«ã§äž¡è
éã®é
åã®çžåæ§ãäœãããšåã³äž¡è
éã§éææé»å®³ 5ãçããããšãèãããããä»®ã«ãéå€ HVT ãšæ¬éºäŒåçµæããŠã€ã«ã¹éã§çµæããèµ·ãã£ãå Žåã«æ³å®ããããŠã€ã«ã¹ã¯ãæ¬éºäŒåçµæããŠã€ã«ã¹ãšåæ§ã® IBDVVP2 ãã³ãŒãããéºäŒåãå«ããŠã€ã«ã¹ã§ãããç
åæ§ä»äžã®å¯èœæ§ã¯ãªããæ¬éºäŒåçµæããŠã€ã«ã¹ã¯ã DNA ãŠã€ã«ã¹ã§ããæ žå
ã§è€è£œãããããIBDV 㯠RNAãŠã€ã«ã¹ã§ãã现è質å
ã§è€è£œããããããéå€ IBDV ãšæ¬éºäŒåçµæããŠã€ã«ã¹ã® IBDVVP2 ã³ãŒãéºäŒåé
åã®äº€æã®å¯èœæ§ã¯æ¥µããŠäœããšèããããã
æµ·å€ãå«ããæ¬éºäŒåçµæããŠã€ã«ã¹ãšé¡äŒŒã® HVT ããã¯ã¿ãŒãšãã HVTIBD ã¯ã¯ãã³ã¯ãåŸæ¥ã®ãã¬ãã¯ç
ã¯ã¯ãã³ãšãšãã«æ¢ã«éå€ã§äœ¿çšãããŠããããçŸåšãŸã§ã«çµæããçãããšããå ±åã¯ãããŠããªãã
MDV ã¯ãŠãºã©ãäžé¢é³¥ãããžãæ°çš®ã®ã«ã¢ãã¬ã³çã®éçæ°ŽçŠœã«ãææãããã宿䞻ãŠã€ã«ã¹ HVT FC126 æ ªã®æææ§ã確èªãããŠããªãåç©çš®ã«ãããŠã宿䞻ãŠã€ã«ã¹ HVT FC126 æ ªã«æåæ§ã®é«ãé¶ãšåç以äžã«ãŠã€ã«ã¹ãææ³ããããšã¯èãããããæææºã«ãªãåŸãªããšèããããã
HVT ã²ãã ã¯ãé¶æè²äœããã¡ã¢ 7å埩é
åã®çžåéºäŒåãæããŠãããææãã现èã®æè²äœã«çµã¿èŸŒãŸããããšããããããããããã¡ã¢é åã¯éºäŒåçºçŸã«é¢ããæ©èœãæãããHVT ã²ãã ã®äžéšãããã¯å
šéšããã®é åãžçµèŸŒãŸãããšããŠããHVT ã®éºäŒå調ç¯å åãé¶ã²ãã äžã®äž»èŠãªéºäŒåãšé£æ¥ããŠããªããããé¶ã²ãã éºäŒåã®çºçŸãå€åãããå¯èœæ§ã¯äœãã
以äžã«ãããæ žé
žãæ°Žå¹³äŒéããæ§è³ªã«èµ·å ããŠåœ±é¿ãåããå¯èœæ§ã®ããéç忀ç©çã¯ç¹å®ãããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããæ žé
žãæ°Žå¹³äŒéããæ§è³ªã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
5 æ¢ã«ææãã现èãžã®åçš®ã®ãŠã€ã«ã¹ã®åææãé²ãããšã
(5)ãã®ä»ã®æ§è³ª
äžèšã®ä»ã«ãæ¬éºäŒåçµæããŠã€ã«ã¹ã«é¢ããŠçç©å€æ§æ§åœ±é¿ã®è©äŸ¡ãè¡ãããšãé©åœã§ãããšèããããæ§è³ªã¯ãªããšå€æããã
(6)çµè«
ä»ã®åŸ®çç©ãæžå°ãããæ§è³ªã«ã€ããŠã¯ã宿䞻 HVT FC126 æ ªåã³ IBDVVP2 èçœè³ªèªäœã«ã¯æ¯æ§ãç
åæ§ããªããIBDVVP2 éºäŒåæ¿å
¥ãµã€ãã¯ãHVT ã²ãã ã®äžã§ç¹ã«ä¿åæ§ã®é«ãé åã§ããã飿¥é åã«ã¯èª¿ç¯å åã®ååšã¯ç¥ãããŠããããæ¬éºäŒåçµæããŠã€ã«ã¹ã®äŸäžæ žé
žã®å®å®æ§ã確èªãããããšãããéºäŒåã®çºçŸçã調ç¯ããæ©èœãæããå¯èœæ§ã䞊ã³ã«ä»ã®åŸ®çç©ã«å¯Ÿããç
åæ§åã³ã¢ã¬ã«ã²ã³ãšãªãç©è³ªãå«ãæå®³ç©è³ªãç£çããå¯èœæ§ã¯æ¥µããŠäœããšå€æãããã
ãŸãã宿䞻 HVT FC126 æ ªãšæ¯èŒããŠæ¬éºäŒåçµæããŠã€ã«ã¹ã®å¢æ®èœã®äžæã¯ã¿ããããé¶ã«ãããäœå
åæ
ãææ³ããã³åå±
æææ§ã¯å®¿äž»ãŠã€ã«ã¹ãšåçšåºŠã§ãã£ãããã¬ãã¯ç
åã¯äŒææ§ãã¡ããªããŠã¹å¢ç
ã«é¢é£ããç
åæ§åŸ©åž°ã¯ç¢ºèªããããå
åšæ§ãŠã€ã«ã¹ã®æŽ»æ§ååã³ç
åæ§ä»äžã®å¯èœæ§ã¯èããããªãããšããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããä»ã®åŸ®çç©ãæžå°ãããæ§è³ªã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããšå€æããã
ç
åæ§ã«ã€ããŠã¯ãæ¬éºäŒåçµæããŠã€ã«ã¹ã¯ IBDV VP2 èçœè³ªãçºçŸããããšä»¥å€ã¯ã宿䞻 HVT FC126 æ ªã®ç¹æ§ãåãç¶ãã§ãããéçåç©ãžã®æææ§ã«é¢ããŠã¯ãäžé¢é³¥ãšç³»çµ±çã«é ãéçé³¥é¡ãžã®èªç¶æææ§ã¯äœããšèãããããæ¬éºäŒåçµæããŠã€ã«ã¹ãæ¥çš®ããé¶ããã®ãŠã€ã«ã¹ã®ææ³åã³åå±
ããé¶ãžã®æ°Žå¹³äŒéã¯ãHVT ã§ã®æ¢ç¥ã®çšåºŠãšåçã§ããããšã瀺ãããæ¬éºäŒåçµæããŠã€ã«ã¹ã®ãã¬ãã¯ç
åã¯äŒææ§ãã¡ããªããŠã¹å¢ç
ãžã®ç
åæ§åŸ©åž°ã¯èŠããããæ¬éºäŒåçµæããŠã€ã«ã¹ãéçåç©ã®çæ¯ã«æ¯éãåãŒãæ§è³ªã«é¢ããŠã¯ãHVT ãšåæ§ã«éåžžã«äœããšèããããããšããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããç
åæ§ã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
æå®³ç©è³ªã®ç£çæ§ã«ã€ããŠã¯ã宿䞻ãŠã€ã«ã¹ã§ãã HVT FC126 æ ªãæå®³ç©è³ªã®ç£çæ§ã¯èªããããŠããããæ¬éºäŒåçµæããŠã€ã«ã¹ã¯ãIBDV VP2 èçœè³ªãçºçŸãã以å€ãåºæ¬çãªçç©åŠçæ§ç¶ã¯å®¿äž»ãŠã€ã«ã¹ãšåäžã§ãããIBDV VP2 èçœè³ªèªäœã«æ¯æ§ãç
åæ§ããªãããŸããéºäŒåçºçŸã«ã»ããã¯ãHVT ã²ãã ã®äžã§ç¹ã«ä¿åæ§ã®é«ãé åã«äœçœ®ããŠããã飿¥é åã«ã¯èª¿ç¯å åã®ååšã¯ç¥ãããŠããªãããéºäŒåã®çºçŸçã調ç¯ããæ©èœãæããå¯èœæ§åã³æå®³ç©è³ªãç£çããå¯èœæ§ã¯æ¥µããŠäœãããšãã¢ããé
žé
åã«ã¢ã¬ã«ã²ã³ãšçžåãªé
åããªãããšããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããæå®³ç©è³ªã®ç£çæ§ã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
æ žé
žãæ°Žå¹³äŒéããæ§è³ªã«ã€ããŠã¯ããã¯ã¬ãªããã¬ãã«ã§ HVT ãš MDVéã®é
åã®çžåæ§ãäœãããšãHVT ãš MDV éã§éææé»å®³ãçããåçš®ãŠã€ã«ã¹ãšã®çžåçµæãã®å¯èœæ§ã«ã€ããŠã®ãªã¹ã¯ã¯æ¥µããŠäœãããšãæ¬éºäŒåçµæããŠã€ã«ã¹ã¯ DNA ãŠã€ã«ã¹ã§ããæ žå
ã§è€è£œããããããRNA ãŠã€ã«ã¹ã§ããéå€ IBDV ãšæ¬éºäŒåçµæããŠã€ã«ã¹ã®éºäŒåé
åã®äº€æã®å¯èœæ§ã¯æ¥µããŠäœãããšã宿䞻ãŠã€ã«ã¹ HVT FC126 æ ªã«æåæ§ã®é«ãé¶ãšåç以äžã«ãŠã€ã«ã¹ãææ³ããããšã¯èãããããæææºã«ãªãåŸãªãããšãé¡äŒŒã® HVT-IBD ã¯ã¯ãã³ã¯ãåŸæ¥ã®ãã¬ãã¯ç
ã¯ã¯ãã³ãšãšãã«æ¢ã«éå€ã§äœ¿çšãããŠããããçŸåšãŸã§ã«çµæããçãããšããå ±åã¯ãããŠããªãããšåã³ææããé¶ã®ã²ãã ããç²åŸãããšèããããŠããããã¡ã¢é åã¯é¶ã²ãã éºäŒåã®çºçŸãå€åãããå¯èœæ§ã¯äœãããšããã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããæ°Žå¹³äŒéã«èµ·å ããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããã®ãšå€æããã
以äžãç·åçã«è©äŸ¡ããåœè©²éºäŒåçµæããŠã€ã«ã¹ã第äžçš®äœ¿çšèŠçšã«åŸã£ã䜿çšãè¡ãéããçç©å€æ§æ§åœ±é¿ãçãããããã¯ãªããšå€æããã
é£æåºŠåé¡ïŒæ°åãäœãã»ã©ã³ã¡ã³ãããããïŒãã¹ããã®ïŒ
| ç·å | 15 䞊㿠|
| é£æåºŠ | 2 â
â
â |
| çæŽ»åœ±é¿åºŠ | 2 â
â
â |
| åé | 3 â
â
â
|
| å°éæ§ | 2 â
â
â |
| çç§ç³»ç¥è | 2 â
â
â |
| äžèª¿èŠåŠ | 2 â
â
â |
| æ³ä»€èªèŸŒèŠåŠ | 2 â
â
â |
#60913 03.蟲氎ç â€ãã®ä»